Verified Nov 2026
Batteries & E-Mobility
·

Seoul
·
Since 2022
Lotte Biologics is a contract development and manufacturing organization (CDMO) for biologics, founded in 2022 as a subsidiary of the Lotte Group and headquartered in Seoul, South Korea. The company operates in the 500–1,000 employee band with estimated revenue of $100–250 million. It serves biopharmaceutical, medical, and renewable-energy sectors through a dual-hub model spanning South Korea and the United States, including facilities at Syracuse Bio Campus in New York and a completed mega plant in Songdo.
Lotte Biologics at a glance
Revenue
$100-250M
Est. band
Employees
500-1,000
Founded
2022
Headquarters
Seoul
Certifications
ISO 45001
Industries
Automotive
Electric Vehicles
Medical
Renewable Energy
Industrial Equipment
STABILITY SIGNALS
Established & active
4 years in operation (founded 2022).
Holds ISO 45001 certification(s) per public sources.
Overview
Lotte Biologics is a contract development and manufacturing organization (CDMO) for biologics, founded in 2022 as a subsidiary of the Lotte Group and headquartered in Seoul, South Korea. The company operates in the 500–1,000 employee band with estimated revenue of $100–250 million. It serves biopharmaceutical, medical, and renewable-energy sectors through a dual-hub model spanning South Korea and the United States, including facilities at Syracuse Bio Campus in New York and a completed mega plant in Songdo.
At a glance
Attribute | Detail |
|---|---|
Founded | 2022 |
Headquarters | Seoul |
Employees | 500-1,000 |
Revenue | $100-250M (estimated) |
Primary capability | Batteries & E-Mobility |
Certifications | ISO 45001 |
What Lotte Biologics makes
Lotte Biologics provides end-to-end CDMO services including process development, drug substance and product manufacturing, analytical services, and antibody-drug conjugate (ADC) manufacturing, and holds ISO 45001 certification.
Products and capabilities described on the company's own site include Steel (source: lottebiologics.com).
Certifications
Lotte Biologics is associated with the following certifications in public sources. Confirm the certified scope for the specific plant producing your part:
ISO 45001 — lottebiologics.com
Latest developments
2026-10-07 — Alvotech and LOTTE Biologics announce US-based manufacturing agreement to increase global supply | LOTTE BIOLOGICS (lottebiologics.com)
2026-06-22 — Lotte Biologics Completes Songdo Plant 1, Boosting CDMO Order Push - Seoul Economic Daily (sedaily.com)
2026-05-18 — LOTTE Biologics Expands Antibody Manufacturing Agreement with Ottimo Pharma | LOTTE BIOLOGICS (lottebiologics.com)
2026-04-06 — LOTTE Biologics Secures Contract Development and Manufacturing Agreement | LOTTE BIOLOGICS (lottebiologics.com)
2026-04-01 — LOTTE Biologics Signs Contract Development and Manufacturing Agreement with U.S.-Based Commercial-Stage Oncology Biotech | LOTTE BIOLOGICS (lottebiologics.com)
2026-01-14 — Rakuten Medical and LOTTE Biologics Sign Manufacturing Agreement to Support Biopharmaceuticals in Global Oncology Program | LOTTE BIOLOGICS (lottebiologics.com)
Facilities
Lotte Biologics is headquartered in Seoul. Public sources also reference these locations:
New York — lottebiologics.com
Syracuse, New York — lottebiologics.com
Company details
The company has secured multiple manufacturing agreements with biopharmaceutical firms, including partnerships announced in 2026 with Alvotech and Ottimo Pharma to expand antibody and biosimilar production capacity. Lotte Biologics was founded in 2022, has an estimated 500-1,000 employees, and is headquartered in Seoul. On the LightSource stability read it is rated "Established & active": 4 years in operation (founded 2022). Holds ISO 45001 certification(s) per public sources.
Frequently asked questions
What does Lotte Biologics make?
Lotte Biologics is a contract development and manufacturing organization (CDMO) for biologics, founded in 2022 as a subsidiary of the Lotte Group and headquartered in Seoul, South Korea. The company operates in the 500–1,000 employee band with estimated revenue of $100–250 million. It serves biopharmaceutical, medical, and renewable-energy sectors through a dual-hub model spanning South Korea and the United States, including facilities at Syracuse Bio Campus in New York and a completed mega plant in Songdo.
Where is Lotte Biologics headquartered?
Lotte Biologics is headquartered in Seoul.
When was Lotte Biologics founded?
Lotte Biologics was founded in 2022.
How big is Lotte Biologics?
Lotte Biologics has an estimated 500-1,000 employees, with revenue in the $100-250M range (estimated).
What certifications does Lotte Biologics hold?
Lotte Biologics lists ISO 45001 on its website. Confirm the certified scope for the specific plant producing your part.
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
